Cargando…

The cost-effectiveness of growth hormone replacement therapy (Genotropin®) in hypopituitary adults in Sweden

BACKGROUND: To evaluate the cost-effectiveness of growth hormone (GH) treatment (Genotropin®) compared with no GH treatment in adults with GH deficiency in a Swedish societal setting. METHODS: A Markov-type cost-utility simulation model was constructed and used to simulate, for men and women, morbid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bolin, Kristian, Sandin, Rickard, Koltowska-Häggström, Maria, Loftus, Jane, Prütz, Christin, Jonsson, Björn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850881/ https://www.ncbi.nlm.nih.gov/pubmed/24079522 http://dx.doi.org/10.1186/1478-7547-11-24

Ejemplares similares

Growth hormone (GH) replacement in hypopituitary adults with GH deficiency evaluated by a utility-weighted quality of life index: a precursor to cost–utility analysis
por: Kołtowska-Häggström, Maria, et al.
Publicado: (2008)

Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy
por: Monson, John P, et al.
Publicado: (2007)

The modulation of platelet function by growth hormone in growth hormone deficient Hypopituitary patients
por: Oglesby, Irene K, et al.
Publicado: (2023)

Mass spectrometrical analysis of recombinant human growth hormone (Genotropin(®)) reveals amino acid substitutions in 2% of the expressed protein
por: Hepner, Felix, et al.
Publicado: (2005)

Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study
por: Child, Christopher J, et al.
Publicado: (2011)

Incidence of Diabetes Mellitus and Evolution of Glucose Parameters in Growth Hormone–Deficient Subjects During Growth Hormone Replacement Therapy: A long-term observational study
por: Luger, Anton, et al.
Publicado: (2012)

Prevalence and risk factors of the metabolic syndrome in young adults with childhood-onset hypopituitary growth hormone deficiency
por: Lim, Han Hyuk, et al.
Publicado: (2010)

Classic cardiovascular risk factors improve in very elderly hypopituitary patients treated on standard hormone replacement in long term follow- up
por: Rosa, Isabella Naves, et al.
Publicado: (2021)

ODP643 Metabolic Effects of Growth Hormone Replacement in Craniopharyngioma and Pituitary Adenoma Patients: Analysis of the Hypopituitary Control and Complications Study (HypoCCS) Database
por: Cooper, Odelia, et al.
Publicado: (2022)

Circulating Levels of Irisin in Hypopituitary and Normal Subjects
por: Pena-Bello, Lara, et al.
Publicado: (2016)

Comparison of Quality of Life Responses From Caregiver and Children Aged ≥7 Years Using the Quality of Life in Short Stature Youth (QoLISSY) Questionnaire, Following 12 Months of Growth Hormone Treatment With Either a Weekly Somatrogon or a Daily Genotropin Injection Schedule
por: Loftus, Jane, et al.
Publicado: (2021)

Physical inactivity: productivity losses and healthcare costs 2002 and 2016 in Sweden
por: Bolin, Kristian
Publicado: (2018)

Intestinal immunity in hypopituitary dwarf mice: effects of age
por: Wang, Xin, et al.
Publicado: (2018)

Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency
por: Elbornsson, Mariam, et al.
Publicado: (2012)

Male-female differences in 6-sulfatoxymelatonin excretion in hypopituitary patients
por: Fideleff, Hugo L., et al.
Publicado: (2015)

Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS)
por: Rochira, V., et al.
Publicado: (2018)

Efficacy and Safety of Once-Weekly Somatrogon Compared with Once-Daily Somatropin (Genotropin®) in Japanese Children with Pediatric Growth Hormone Deficiency: Results from a Randomized Phase 3 Study
por: Horikawa, Reiko, et al.
Publicado: (2022)

Higher hydrocortisone dose increases bilirubin in hypopituitary patients‐ results from an RCT
por: Werumeus Buning, Jorien, et al.
Publicado: (2016)

Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients
por: Yuan, Xian-Xian, et al.
Publicado: (2019)

Evaluation of ICD-10 algorithms to identify hypopituitary patients in the Danish National Patient Registry
por: Berglund, Agnethe, et al.
Publicado: (2017)

Hypopituitary syndrome with pituitary crisis in a patient with traumatic shock: A case report
por: Zhang, Xing-Cheng, et al.
Publicado: (2022)

RF26 | PSAT150 Growth Outcomes From the Phase 2 and Phase 3 Studies of Once Weekly Somatrogon vs Daily Genotropin in Pediatric Patients With Growth Hormone Deficiency: Comparisons With Published Literature and an International Growth Study Database
por: Cara, Jose, et al.
Publicado: (2022)

Healthcare costs and productivity losses associated with county‐based home‐care service for sick children in Sweden
por: Castor, Charlotte, et al.
Publicado: (2020)

Adult mortality or morbidity is not increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment: an analysis of the Hypopituitary Control and Complications Study (HypoCCS)
por: Mo, Daojun, et al.
Publicado: (2013)

Adaptation of the QoL-AGHDA scale for adults with growth hormone deficiency in four Slavic languages
por: McKenna, Stephen P, et al.
Publicado: (2011)

Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis
por: Redig, Josefine, et al.
Publicado: (2019)

The increase in renal replacement therapy (RRT) incidence has come to an end in Sweden—analysis of variations by region over the period 1991–2010
por: Qureshi, Abdul Rashid, et al.
Publicado: (2013)

SUN-300 Improvement in Cardiovascular Risk Factors in Long Term Follow up of Hypopituitary Septagenarian and Octagenarian Patients
por: Rosa, Isabella Naves, et al.
Publicado: (2020)

COVID-19 vaccination in pregnant women in Sweden and Norway
por: Örtqvist, Anne K., et al.
Publicado: (2022)

Comparison of factors influencing patient choice of community pharmacy in Poland and in the UK, and identification of components of pharmaceutical care
por: Merks, Piotr, et al.
Publicado: (2014)

Long‐lived hypopituitary Ames dwarf mice are resistant to the detrimental effects of high‐fat diet on metabolic function and energy expenditure
por: Hill, Cristal M., et al.
Publicado: (2016)

OR32-05 Lower Oxytocin Levels Are Associated with Lower Bone Mineral Density and Less Favorable Hip Geometry in Hypopituitary Men
por: Maso, Ana Aulinas, et al.
Publicado: (2020)

Cost of Illness for Five Major Foodborne Illnesses and Sequelae in Sweden
por: Sundström, Kristian
Publicado: (2018)

Cost Analysis of a Digital Health Care Model in Sweden
por: Ekman, Björn
Publicado: (2017)

Invisible Scars or Open Wounds? The Role of Mid-career Income for the Gender Pension Gap in Sweden
por: König, Stefanie, et al.
Publicado: (2019)

Optimizing cost-efficiency in mean exposure assessment - cost functions reconsidered
por: Mathiassen, Svend Erik, et al.
Publicado: (2011)

Trends in haemoglobin levels from 1968 to 2017 and association with hormonal contraceptives: observations from the population study of women in Gothenburg, Sweden
por: Sandin, Linda, et al.
Publicado: (2023)

Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden
por: Jamookeeah, Clare, et al.
Publicado: (2016)

Food and Nutrient Intake during Pregnancy in Relation to Maternal Characteristics: Results from the NICE Birth Cohort in Northern Sweden
por: Stråvik, Mia, et al.
Publicado: (2019)

Disability risks in past populations: Sweden from the 1800s until 1959
por: Vikström, L, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sgah9jhf61c4i3lr67b1ja6uoo